Application of built-in adjuvants for epitope-based vaccines

Several studies have shown that epitope vaccines exhibit substantial advantages over conventional vaccines. However, epitope vaccines are associated with limited immunity, which can be overcome by conjugating antigenic epitopes with built-in adjuvants (e.g., some carrier proteins or new biomaterials...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yao, Zhao, Furong, Shao, Junjun, Li, Yangfan, Li, Shifang, Chang, Huiyun, Zhang, Yongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336016/
https://www.ncbi.nlm.nih.gov/pubmed/30656066
http://dx.doi.org/10.7717/peerj.6185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336016/
https://www.ncbi.nlm.nih.gov/pubmed/30656066
http://dx.doi.org/10.7717/peerj.6185

Ejemplares similares